BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 4946253)

  • 1. In vivo evaluation of antibacterial chemotherapeutic substances.
    Miller AK
    Adv Appl Microbiol; 1971; 14():151-83. PubMed ID: 4946253
    [No Abstract]   [Full Text] [Related]  

  • 2. Tobramycin: an overview.
    Neu HC
    J Infect Dis; 1976 Aug; 134 Suppl():S3-19. PubMed ID: 787451
    [No Abstract]   [Full Text] [Related]  

  • 3. Assessment of the cost/effectiveness of chemotherapy for skin and urinary tract infections using in vitro sensitivity testing.
    Stanaway L
    N Z Med J; 1979 Sep; 90(643):201-3. PubMed ID: 117404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative clinical evaluation of mezlocillin and cefoxitin.
    LeFrock JL; Molavi A; Carr B; Schell R; Smith B; Rolston K; Lentnek A
    J Antimicrob Chemother; 1982 Jan; 9 Suppl A():199-203. PubMed ID: 6210667
    [No Abstract]   [Full Text] [Related]  

  • 5. [Sensitivity of some bacterial species isolated from urinary infections to antimicrobial agents].
    Meitert E; Sima F; Savulian C; Chersulick E; Petrescu AM
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1984; 29(2):145-54. PubMed ID: 6463514
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibiotics and skin infections: when to use local or systemic measures.
    Bremner DA
    Drugs; 1977 Jan; 13(1):52-6. PubMed ID: 832615
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical evaluation of ceftriaxone in the pediatric field].
    Hoshina H; Hirosawa H; Mikuni K; Ichihashi H
    Jpn J Antibiot; 1984 Nov; 37(11):2027-33. PubMed ID: 6098699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic treatment of soft-tissue infections.
    Lancet; 1973 Mar; 1(7802):544-5. PubMed ID: 4119967
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antibacterial therapy of urinary tract infections].
    Ukhin AV
    Antibiot Khimioter; 1989 Apr; 34(4):299-304. PubMed ID: 2665677
    [No Abstract]   [Full Text] [Related]  

  • 10. [Theoretical and practical significance of resistance of the urinary bacterial flora to chemoantibiotics].
    Porta F; Romero E
    Quad Sclavo Diagn; 1972 Dec; 8(4):1111-22. PubMed ID: 4668734
    [No Abstract]   [Full Text] [Related]  

  • 11. [Guidelines of the SFAR (Société Française d'Anesthésie et de Réanimation). Antibiotic combinations or monotherapy in surgery and surgical intensive care. Extracts relating to the "visceral surgery" conference of experts].
    Auboyer C
    J Chir (Paris); 2000 Dec; 137(6):333-6. PubMed ID: 11119027
    [No Abstract]   [Full Text] [Related]  

  • 12. The rational use of antibiotics in general practice.
    Steele TW; Rich GE
    Aust Fam Physician; 1977 May; 6(5):486-95. PubMed ID: 560184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pathogens of urinary tract infections in ambulatory care--resistance status and pathogen spectrum].
    Fille M; Allerberger F; Dierich MP
    Wien Klin Wochenschr; 1989 Mar; 101(7):219-21. PubMed ID: 2711695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Rimactan. Experimental studies and clinical experience].
    Meyer-Rohn J; Lautenschlager HJ
    Munch Med Wochenschr; 1969 Aug; 111(33):1646-50. PubMed ID: 5395306
    [No Abstract]   [Full Text] [Related]  

  • 15. [Tobramycin. Bacteriological studies and clinical activity in urinary and extra-urinary infections].
    Abbate GF; Alagia I; Gattoni A; Leonessa V; Manguso L; Altucci P
    G Ital Chemioter; 1977; 24(1-2):33-7. PubMed ID: 615760
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of common infectious disorders.
    Kalis PM; Le Frock JL; Prince RA; Jacknowitz AI
    W V Med J; 1976 Jun; 72(6):135-45. PubMed ID: 1064245
    [No Abstract]   [Full Text] [Related]  

  • 17. [Preventive use of anti-bacterial agents].
    Bruun JN
    Tidsskr Nor Laegeforen; 1974 Apr; 94(12):787-9. PubMed ID: 4830343
    [No Abstract]   [Full Text] [Related]  

  • 18. Nifuratrone, a new nitrofuran: in vitro and in vivo activities.
    Ritter HW; Hoffmann PF; Ledbetter RR; Krueger RF
    Antimicrob Agents Chemother (Bethesda); 1970; 10():254-9. PubMed ID: 4939734
    [No Abstract]   [Full Text] [Related]  

  • 19. Infectious complications in diabetic patients.
    File TM; Tan JS
    Curr Ther Endocrinol Metab; 1994; 5():452-7. PubMed ID: 7704772
    [No Abstract]   [Full Text] [Related]  

  • 20. Fosfomycin. Controlled clinical studies.
    Rodriguez A; Olay T; Vicente MV; Oliver LE
    G Ital Chemioter; 1977; 23(2):127-32. PubMed ID: 342325
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.